Merit Medical Systems Inc., a South Jordan-based manufacturer and marketer of healthcare technology, has announced the acquisition of product lines from two companies that will strengthen its dialysis and biopsy markets position. The company bought a portfolio of dialysis catheter products and the BioSentry Biopsy Tract Sealant System from AngioDynamics Inc. of Latham, New York, for $100 million in cash. Merit also paid $32.5 million to Bluegrass Vascular Technologies Inc. of San Antonio, Texas, for its Surface Inside-Out Access Catheter System product line.
“We are selectively investing to expand our{mprestriction ids="1,3"} product portfolio in key strategic markets that leverage our existing commercial footprint,” said Fred P. Lampropoulos, Merit’s chairman and CEO. “These acquisitions strengthen our position in the dialysis and biopsy markets and expand the foundation of our growing specialty dialysis device offering. Many dialysis patients rely on these solutions to receive vital therapies. Combining this broad portfolio of interventional solutions within Merit will allow us to leverage our physician relationships and commercial infrastructure to serve more patients in the multi-billion dialysis market.”
Founded in 1987, Merit Medical Systems serves client hospitals worldwide with a domestic and international sales force and clinical support team totaling in excess of 700 people. Merit employs approximately 7,100 people worldwide with facilities in South Jordan; Pearland, Texas; Richmond, Virginia; Aliso Viejo, California; Maastricht and Venlo, The Netherlands; Paris, France; Galway, Ireland; Beijing, China; Tijuana, Mexico; Joinville, Brazil; Ontario, Canada; Melbourne, Australia; Tokyo, Japan; Reading, United Kingdom; Johannesburg, South Africa; and Singapore.{/mprestriction}
